# 00 — Review Summary (Module 1: Brainstorming)

**Project:** Patient Management System — Phase 1 (localhost learning project)
**Source of truth:** `BRD/Doc_BRD.md` (amended 2026-11-10; planning decisions PDR-01 to PDR-32)
**Status:** Module 1 refreshed 2026-11-10. Module 2 (Planning) is complete and awaiting review: see `Documentation/02-Planning/00-Planning-Review-Package.md`.
**Update 2026-11-10:** Decisions D-1 to D-6 are resolved (see §5). The BRD carries the decided wording and proposed MoSCoW priorities.

---

## 1. What Was Produced

| # | Artifact | File |
|---|---|---|
| 00 | Review Summary | `00-Review-Summary.md` (this file) |
| 01 | BRD Summary | `01-BRD-Summary.md` |
| 02 | Business Objectives | `02-Business-Objectives.md` |
| 03 | Scope Analysis | `03-Scope-Analysis.md` |
| 04 | Stakeholder Analysis | `04-Stakeholder-Analysis.md` |
| 05 | Functional Requirements | `05-Functional-Requirements.md` |
| 06 | Non-Functional Requirements | `06-Non-Functional-Requirements.md` |
| 07 | Assumptions Log | `07-Assumptions-Log.md` |
| 08 | Risk Register | `08-Risk-Register.md` |
| 09 | Constraints Register | `09-Constraints-Register.md` |
| 10 | Acceptance Criteria | `10-Acceptance-Criteria.md` |
| 11 | Requirement Catalog | `11-Requirement-Catalog.md` |
| 12 | Requirement Traceability Matrix | `12-Requirement-Traceability-Matrix.md` |
| 13 | Open Questions | `13-Open-Questions.md` |
| 14 | Decision and Issue Log | `14-Decision-and-Issue-Log.md` |
| 15 | Pre-Commit Decision Summary | `15-Pre-Commit-Decision-Summary.md` |

All Module 1 files are in `Documentation/01-Brainstorming/`. They are uncommitted (user instruction).

## 2. Coverage at a Glance

| Item | Count |
|---|---|
| Functional requirements (FR-*) | 20 (all in scope) |
| Non-functional requirements (NFR-*) | 9 (7 in scope; NFR-REL-001 and NFR-REL-002 deferred) |
| Success criteria (SC-*) | 6 (4 in scope; SC-003 and SC-006 deferred) |
| In-scope BRD scope items | 11 (mapped in `03-Scope-Analysis.md` §1) |
| Out-of-scope items (OOS-*) | 15 |
| Business objectives (BO-*) | 7 |
| Stakeholders (STK-*) | 6 (single decision-maker; see `04-`) |
| Constraints (CON-*) | 23 |
| Risks (RSK-*) | 15 (see `08-`; 5 closed, 3 mitigated, 5 accepted, 2 open) |
| Assumptions (A-*) | 6 (A-001 to A-006) |
| Open questions (OQ-*) | 28: 24 answered, 3 deferred, 1 excluded, **0 open** |
| In-scope requirements traced (no open question) | 31 of 35 (4 deferred) |

## 3. Key Findings (now resolved)

1. **Core clinical entity defined.** Consultation and visit are the same record. It can exist without an appointment (OQ-006, OQ-028).
2. **Success criteria are measurable on localhost.** SC-001, SC-002, NFR-PRF-001 and NFR-PRF-002 are measured on localhost test data. SC-003 and SC-006 are deferred (OQ-020, OQ-021, OOS-014).
3. **Security defined, with exceptions.** Login, password rules, 24-hour sliding timeout, reset flow, TDE at rest and TLS beyond localhost are specified (OQ-015, OQ-016). Regulation and retention are deferred (OQ-017, OOS-015).
4. **Backup and recovery deferred** (OQ-018, OQ-019, OOS-011). NFR-REL-001 and NFR-REL-002 are not in Phase 1.
5. **BRD open-questions section updated** (OQ-027).
6. **Priorities approved.** MoSCoW is in the BRD and was approved by the Project Owner on 2026-11-10 (A-006).
7. **Roles resolved.** One person is Clinic Owner, General Physician, Product Owner and Project Owner (OQ-026).

Still open: none. The appointment lifecycle (PDR-08) and MoSCoW approval (A-006) were resolved on 2026-11-10.

## 4. Rules Followed

- BRD is the single source of truth. Every decided wording change is in the BRD (2026-11-10).
- Module 1 only. Planning and architecture are in `Documentation/02-Planning/`.
- No assumptions. Gaps were logged as open questions and are now answered, deferred or excluded.
- No scope creep. Boundary features are in `03-Scope-Analysis.md` §3.

## 5. Decisions from Reviewer (status)

| # | Decision | Status (2026-11-10) |
|---|---|---|
| D-1 | Confirm A-001: the BRD is the current baseline | Accepted by requester, who is the sole decision-maker (DEC-010). BRD amended 2026-11-10 |
| D-2 | Confirm A-002: this is Module 1 of Phase 1 | Accepted by requester (DEC-002) |
| D-3 | Confirm A-003: the ID scheme from the earlier governance file (`CLAUDE.md`, now deleted; recovered from git history) | Accepted by requester (DEC-003) |
| D-4 | Route the 28 open questions to proposed owners (A-004) | Done. Owners recorded in `14-` (ISS-001 to ISS-028); all answered |
| D-5 | Add requirement priorities to the BRD | Done. MoSCoW approved by the Project Owner on 2026-11-10 (A-006, DEC-006) |
| D-6 | OQ-025 (audit trail) and OQ-017 (retention, consent) in or out of Phase 1 | Decided: OQ-025 excluded (OOS-013); OQ-017 deferred (OOS-015) |

## 6. Next Steps

1. No Project Owner decisions are pending for Module 1 or Module 2. PDR-08 and A-006 were resolved on 2026-11-10.
2. Reviewer reviews Module 2 (`Documentation/02-Planning/00-Planning-Review-Package.md`).
3. Implementation starts when the user instructs it, committed directly to `development` after each approval.

## 7. Not Done

- Documentation is committed to `development` (D-1, approved 2026-11-10). `development` is the only working branch. Nothing is pushed to `main` until a release is approved.
- No implementation.
